Bristol-Myers Squibb 10K 2016 Annual report | BMY Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: academic, Arabia, ASCT, ASR, Biomedical, border, breadth, buy, cabiralizumab, capsule, categorize, characteristic, children, cHL, complementary, compulsive, concise, constraint, Cormorant, cybersecurity, deem, Denko, depth, enable, enabling, excise, expedient, footprint, foster, gambling, gather, GDD, Goldman, guarantee, Gulf, hardware, impulse, insufficient, IO, JMHLW, kg, leaner, margin, Morgan, mUC, narrow, newer, Nitto, Northern, OTC, PAD, Padlock, pembrolizumab, Perfalgan, platinum, powder, prejudice, pretreated, prevalent, rapidly, realign, realigned, recovery, restate, Saudi, SCCHN, SCLC, screen, Seattle, setback, siRNA, sophistication, Stanley, step, substantive, terrorism, vedotin, war, Ximency

Removed: achieving, adjacent, agree, alleging, anticancer, Apothecon, argument, aripiprazole, arm, atypical, avoid, battle, Benckiser, binding, block, body, BOE, boosting, Breakthrough, Cal, Canadian, carcinoma, cell, cetuximab, challenging, chapter, check, Citigroup, cohort, collect, commenced, Commonwealth, comparing, comprised, Connecticut, constitute, contacted, contracted, Corporation, County, cure, cyber, daewoong, daily, defendant, defray, delinquent, demonstrating, designation, desirable, direction, distributed, divest, DNA, EBITDA, EGFR, Eli, embolism, encompassed, enjoining, entecavir, Epidermal, evidentiary, exceeded, expended, expert, exploratory, Fast, FDC, feet, filer, Fill, fiscal, floor, formula, fraudulent, fund, gastroesophageal, gastrointestinal, globally, ground, Hanmi, heavy, highlighted, Identification, immune, immunodeficiency, impeded, incremental, indirectly, inflated, informal, initiated, initiative, injuring, Inspector, intention, Interactive, Interbank, intervene, invalidating, irinotecan, issuer, judge, jury, knowledge, Kombiglyze, Korean, leased, liable, lie, locoregional, London, mark, matured, mCRC, Medarex, median, mediation, methotrexate, metoclopramide, Ministry, misrepresentation, modifying, moved, necitumumab, negligent, neighboring, neuroscience, NJ, NJDEP, nonvalvular, Norvir, Nutrition, NVAF, opportunity, Pennsylvania, pharmacoenhancing, pharmacovigilence, Pharmacy, pioneering, placebo, plc, pleasure, polymerase, predecessor, programmed, prostate, pulmonary, qui, radiation, randomized, realize, receiving, receptor, recourse, redeemed, reflux, regionally, Reglan, reinstatement, renal, repaid, requesting, residential, responded, restructured, resumed, retroactive, returned, returning, ritonavir, ruled, schedule, seasoned, served, shell, space, square, standpoint, studied, sulfate, Supreme, surface, survival, tam, Telephone, Teva, Track, transmitted, transplant, trend, uncollectibility, undergone, undertaken, unlock, unplanned, unsealed, update, uphold, verdict, violation, virologic, voluntarily, warfarin, Washington, web, wholesale, Wisconsin, won

Bristol-Myers Squibb (BMY) 10-K2016 FY Annual report

Content analysis